Neogen Patents – Key Insights and Stats

Neogen has a total of 279 patents globally, out of which 189 have been granted. Of these 279 patents, more than 50% patents are active. The United States of America is where Neogen has filed the maximum number of patents, followed by Europe and Canada. Parallelly, USA seems to be the main focused R&D centre and also is the origin country of Neogen.

Neogen was founded in 1982 by Ted Doan and James Herbert. Neogen Corporation provides a comprehensive range of solutions and services for the food processing, animal protein, and agriculture industries. The Company’s diagnostic products are used by food and animal producers to test for foodborne bacteria, food allergen, natural toxins, drug and chemical residues, plant diseases, and quality assurance. Neogen serves customers globally. As of August 2022, Neogen has a market cap of $ 2.226 Billion.

Do read about some of the most popular patents of Neogen which have been covered by us in this article and also you can find Neogen patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Neogen patent portfolio.

How many patents does the Founder and CEO of Neogen have?

The Founder Ted Doan has 0 patents and James Herbert has 0 patents and CEO John Adent have 2 patents.

How many patents does Neogen have?

Neogen has a total of 279 patents globally. These patents belong to 93 unique patent families. Out of 279 patents, 130 patents are active.

How Many Patents did Neogen File Every Year?

Neogen Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantNeogen Applications FiledNeogen Patents Granted
2011137
2012411
20131019
2014176
2015168
2016156
20174513
2018516
2019313
20201014
202128
20225

How many Neogen patents are Alive/Dead?

Worldwide Patents

Neogen Patents Portfolio

How Many Patents did Neogen File in Different Countries?

Neogen Worldwide Patents

Countries in which Neogen Filed Patents

CountryPatents
United States Of America88
Canada22
Europe21
Germany19
Australia15
Brazil12
Denmark9
New Zealand8
Mexico7
Japan7
Belgium6
China6
United Kingdom6
Poland5
Spain8
Austria3
Korea3
Israel3
Cambodia2
Hong Kong2
Portugal1
Russia1
Viet Nam1

Where are Research Centers of Neogen Patents Located?

Research Centers of Neogen Patents

10 Best Neogen Patents

US6858020B2 is the most popular patent in the Neogen portfolio. It has received 136 citations so far from companies like Dexcom, Carticept Medical, Osprey Medical.

Below is the list of 10 most cited patents of Neogen:

Publication NumberCitation Count
US6858020B2136
US20060216196A153
US6927851B251
US6548018B240
US6565538B239
US6653147B235
US6887681B233
US20040219620A133
US20040096356A125
US6881554B223

What Percentage of Neogen US Patent Applications were Granted?

Neogen (Excluding its subsidiaries) has filed 71 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 46 have been granted leading to a grant rate of 73.02%.

Below are the key stats of Neogen patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Neogen?

Law FirmTotal ApplicationsSuccess Rate
Jonathan P O Brien5684.31%
Butzel Long620.00%
Ian C Mcleod40%
James M Deimen350.00%
Mcleod & Moyne1100.00%
Wenderoth Lind & Ponack10%

EXCLUSIVE INSIGHTS COMING SOON!

What are Neogen key innovation segments?

What Technologies are Covered by Neogen?

The chart below distributes patents filed by Neogen in different countries on the basis of the technology protected in patents. It also represents the markets where Neogen thinks it’s important to protect particular technology inventions.

R&D Focus: How has Neogen search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Neogen?

Updated on August 29, 2022

Was this article helpful?

Leave a Comment